Docusign's new IAM drives ARR growth and retention. Management targets 18% ARR by FY2027; stock looks undervalued (P/E 10.8).
Ternium (TX) rebounds above $40; bullish technicals, Mexico/LatAm expansion, and EPS outlook—yet cyclical risks loom.
A new medical initiative plans to expand care, especially through holistic approaches, to serve Islanders who experience ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory ...
ServiceNow’s recent acquisitions of Moveworks, Armis, and Veza are boosting the company’s conversational AI, AI security, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results